Evidence mapPaperPMID 39355345Full record

ReviewWorld journal of gastrointestinal pathophysiology2024

Microbiome as an endocrine organ and its relationship with eye diseases: Effective factors and new targeted approaches.

Leila Haghshenas, Sara Banihashemi, Yalda Malekzadegan, Roberto Catanzaro, Amir Moghadam Ahmadi, Francesco Marotta

Abstract readReview
In one paragraph

Review in World journal of gastrointestinal pathophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leila HaghshenasDepartment of Clinical Bioinformatics, Harvard Medical School, Boston, MA 02115, United States. leilahagh@yahoo.com.
Sara BanihashemiDepartment of Bioscience, School of Science and Technology, Nottingham Trend University, Nottingham NG1 4FQ, United Kingdom.
Yalda MalekzadeganDepartment of Microbiology, Saveh University of Medical Sciences, Saveh 3919676651, Iran.
Roberto CatanzaroDepartment of Clinical and Experimental Medicine, University of Catania, Catania 95123, Catania, Italy.
Amir Moghadam AhmadiDepartment of Neuroimmunology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, United States.
Francesco MarottaDepartment of Human Nutrition and Food Sciences, Texas Women University, Milano 20154, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbiome is an endocrine organ that refers to both the complicated biological system of microbial species that colonize our bodies and their genomes and surroundings. Recent studies confirm the connection between the microbiome and eye diseases, which are involved in the pathogenesis of eye diseases, including age-related macular disorders, diabetic retinopathy, glaucoma, retinitis pigmentosa, dry eye, and uveitis. The aim of this review is to investigate the microbiome in relation to eye health. First, a brief introduction of the characteristics of the gut microorganisms terms of composition and work, the role of dysbiosis, the gut microbiome and the eye microbiome in the progression of eye illnesses are highlighted, then the relationship among the microbiome and the function of the immune system and eye diseases, the role of inflammation and aging and the immune system, It has been reviewed and finally, the control and treatment goals of microbiome and eye diseases, the role of food factors and supplements, biotherapy and antibiotics in relation to microbiome and eye health have been reviewed.

Indexed as

AgingDiabetic retinopatyhyDysbiosisEye diseasesGut microbiomeInflammationNutrient supplementation

Identifiers

PMID39355345
PMCPMC11440246

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.